+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Acute effect of nasal continuous positive airway pressure therapy on the systemic immunity of patients with obstructive sleep apnea syndrome



Acute effect of nasal continuous positive airway pressure therapy on the systemic immunity of patients with obstructive sleep apnea syndrome



Sleep 24(5): 545-553



Objectives: To investigate whether in patients with obstructive sleep apnea syndrome (OSAS) the systemic immunity is disturbed and whether it changes with nasal continuous positive airway pressure (NCPAP) therapy. Design: Polysomnography was performed on 18 OSAS patients (Group A) before NCPAP was started and again on the first night of NCPAP. Blood samples were collected at 8:00PM, 1:00AM and 6:00AM during each polysomnography. Lymphocyte subsets, lymphocyte blastformation, and natural killer (NK) cell activity were determined. Six normal subjects were also studied. A different six OSAS patients were studied over 6 days of NCPAP. Setting: N/A Patients or Participants: N/A Interventions: N/A Measurements and Results: The only immunological parameter that significantly differed between the Group A OSAS patients either before or on the first night of NCPAP, and the normal subjects was the epinephrine level. Among the Group A OSAS patients, the following immunological parameters were significantly lower at 6:00AM on the first night of NCPAP than before NCPAP was started: percentage (49.4 +- 1.9% before NCPAP vs 45.7 +- 2.0% with NCPAP, mean +- SEM, p < 0.005) and absolute count of CD4+ cells (944.1 +- 63.8 vs 829.6 +- 71.3/mm3, p < 0.05); absolute count of CD4+HLA-DR+ cells (91.9 +- 13.3 vs 75.1 +- 8.9/mm3, p < 0.05); CD4+/CD8+ ratio (2.13 +- 0.21 vs 1.91 +- 0.18, p < 0.05). The reduction in the percentage of CD4+ cells at 6:00AM was significantly correlated with the change in apnea-hypopnea index (AHI) (r = 0.729, p < 0.01). The CD4+ cell count recovered after 6 days of NCPAP. The lymphocyte blastformation and NK cell activity levels did not change with NCPAP. Conclusions: First-night NCPAP therapy reduced the CD4+ cell count after sleep, which recovered after one week of NCPAP. OSAS patients do not have immunological abnormalities.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010125240

Download citation: RISBibTeXText

PMID: 11480652

DOI: 10.1093/sleep/24.5.545


Related references

Effect of adherence on daytime sleepiness, fatigue, depression and sleep quality in the obstructive sleep apnea/hypopnea syndrome patients undertaking nasal continuous positive airway pressure therapy. Patient Preference and Adherence 11: 769-779, 2017

Effects of nasal continuous positive airway pressure therapy on respiratory parameters of upper airway patency in patients with obstructive sleep apnea syndrome. Chest 114(3): 691-696, 1998

Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome. Sleep Medicine 10(1): 87-94, 2009

Therapy with nasal CPAP (continuous positive airway pressure) in patients with obstructive sleep apnea syndrome (OSAS). II: Side-effects of nCPAP therapy. Effect on long-term acceptance. Laryngo- Rhino- Otologie 76(10): 608-613, 1998

Impact of nasal continuous positive airway pressure therapy on the quality of life of bed partners of patients with obstructive sleep apnea syndrome. Chest 124(6): 2209-2214, 2003

Effects of long-term nasal continuous positive airway pressure therapy on morphology, function, and mucociliary clearance of nasal epithelium in patients with obstructive sleep apnea syndrome. Laryngoscope 114(8): 1431-1434, 2004

Nasal continuous positive airway pressure therapy in obstructive sleep apnea syndrome. Zhonghua Jie he He Hu Xi Za Zhi 14(4): 225-7 256, 1991

Effect of Nasal Continuous Positive Airway Pressure in Uncontrolled Nocturnal Asthmatic Patients With Obstructive Sleep Apnea Syndrome. Yearbook of Pulmonary Disease 2006: 237-238, 2006

Effect of nasal continuous positive airway pressure in uncontrolled nocturnal asthmatic patients with obstructive sleep apnea syndrome. Respiratory Medicine 99(5): 529-534, 2005

Proton MR spectroscopy study of brain metabolism in patients with obstructive sleep apnea syndrome before and after nasal continuous positive airway pressure therapy. Neurology 60(5 Suppl. 1): A10, 2003

Histology of nasal mucosa in untreated obstructive sleep apnea syndrome and during nasal continuous positive airway pressure therapy. FASEB Journal 16(4): A359-A360, 2002

Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100(7): 706-712, 1999

Daytime hypercapnia in adult patients with obstructive sleep apnea syndrome in France, before initiating nocturnal nasal continuous positive airway pressure therapy. Chest 127(3): 710-715, 2005

Effect of Nasal Continuous Positive Airway Pressure Therapy on the Functional Respiratory Parameters and Cardiopulmonary Exercise Test in Obstructive Sleep Apnea Syndrome. Turkish Thoracic Journal 17(1): 1-6, 2016

Therapy with nasal CPAP (continuous positive airway pressure) in patients with obstructive sleep apnea syndrome (OSAS). I: Long-term acceptance of nasal CPAP. Laryngo- Rhino- Otologie 76(9): 550-553, 1998